Continuing Education Credit Information - American Society of ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Continuing Education Credit Information
Program Description and Learning Objectives
Accreditation Information, Types of Credit, Claiming Credit
Scientific Program
Disclosures
April 5th - 8th, 2022
Program Description and Learning Objectives
Target Audience
The educational design of this activity addresses the needs of healthcare professionals (physicians,
surgeons, pharmacists, nurses, and others) and researchers working in the field of transplantation.
Educational Objectives
The following overarching objectives and more specific goals have been identified for this meeting. Having
participated in this meeting, attendees will be able to:
• Review how key stakeholders in transplantation define success.
• Identify innovations in transplant medicine during and since the pandemic that have worked and use
this knowledge to strategize future interventions.
• Discuss advances in mitigating infections and antibody mediated Injury – The Yin and the Yang of
transplant medicine.
Statement of Need/Program Overview
CEoT 2022 will be an exciting exploration of primary stakeholders in organ transplantation coming together
to define ideal metrics to drive equity and quality in transplant access and outcomes and discuss the key
challenges that the transplant field must overcome to develop and implement these quality metrics in clinical
practice.
The stage will be set by looking at current definitions of success from all key stakeholders - federal,
insurers, patients, care providers and understanding the implications of having different stakeholders whose
perspectives on success do not always align. The program will then delve into potential alternatives
definitions of success at the societal and systems levels as well as for patients and caregivers. Tying in the
themes from the ASHI meeting that CEOT 2022 immediately follows, each organ and the infectious disease
group with specialized tracks will delve into the Yin and Yang of infection and rejection on the spectrum of
immunosuppression. The overarching goal is to systematically examine and refine definitions of success for
all stakeholders in transplantation to inform and reframe future conversations in organ transplantation.Accreditation Information, Types of Credit, Claiming Credit This activity is jointly provided by Global Education Group and the American Society of Transplantation. This activity is supported by educational grants from CSL Behring, Mallinckrodt and Takeda.
Commercial Support Commercial support provided by ASHI, CareDx, CSL Behring, Eurofins, Immucor, Hansa, Mallinckrodt, Natera, Nephrosant, Sanofi Genzyme, Takeda, Talaris Therapeutics, Terasaki Innovation Center, Transplant Connect, Veloxis.
How to Claim Credit
Following the meeting, all participants will receive a link to an online evaluation form. After completing this
evaluation, participants may claim a certificate noting the appropriate amount of credit or request a general
certificate of attendance.
For pharmacist learners, partial credit may not be awarded, so sessions must be attended in their entirety to
claim credit.
Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and
policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint
providership of Global Education Group (Global) and American Society of Transplantation. Global is
accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this live activity for 18 AMA PRA Category 1 Credits™. Physicians
should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy
Education as a provider of continuing pharmacy education.
Global Education Group designates this continuing education activity for 18 contact hour(s) (1.8 CEUs) of the
Accreditation Council for Pharmacy Education.
Please see www.myAST.org/CEOT for full ACPE information and UAN numbers.
Credit Date and Time Title UAN
Hours
1.0 4/5/2022 – 10:05-11:05 AM STAR Pre-Meeting Workshop 0530-9999-22-040-L01-P
The Role of non-HLA antibody testing
1.0 4/5/2022 – 11:05-12:05 PM STAR Pre-Meeting Workshop 0530-9999-22-041-L01-P
Measurement of HLA antibodies to
assess efficacy of therapy
.75 4/5/2022 – 12:15-1:05 PM STAR Pre-Meeting Workshop
Tests to identify HLA antibody 0530-9999-22-042-L01-P
attributes
1.25 4/5/2022 –1:05- 2:15 PM STAR Pre-Meeting Workshop 0530-9999-22-043-L01-P
Alloimmune memory
Primary alloimmunity
1.5 4/6/2022 – 10:00-11:30 AM Welcome and Session 1 0530-9999-22-044-L01-P
“You Call that Success?”: Redefining
the Transplant Ideal
1.5 4/6/2022 – 1:45-3:15 PM Session 2: Redefining Success in 0530-9999-22-045-L01-P
Transplantation: How Can We Do
Better
1.0 4/6/2022 – 3:45-4:45 PM Keynote Speaker 0530-9999-22-046-L01-P
1.5 4/7/2022 – 10:00-11:30 AM Session 3: Pathway to Success: 0530-9999-22-047-L01-P
Overcoming Rejection (Organ
Breakouts) Option 1: Heart
1.5 4/7/2022 – 10:00-11:30 AM Session 3: Pathway to Success: 0530-9999-22-048-L01-P
Overcoming Rejection (Organ
Breakouts) Option 2: Kidney1.5 4/7/2022 – 10:00-11:30 AM Session 3: Pathway to Success: 0530-9999-22-049-L01-P
Overcoming Rejection (Organ
Breakouts) Option 3: Liver
1.5 4/7/2022 – 10:00-11:30 AM Session 3: Pathway to Success: 0530-9999-22-050-L01-P
Overcoming Rejection (Organ
Breakouts) Option 4: Lung
1.5 4/7/2022 – 10:00-11:30 AM Session 3: Option 5: Transplant 0530-9999-22-051-L01-P
Infectious Diseases
1.25 4/7/2022 – 12:00-1:15 PM Satellite Symposium Presented by CSL 0530-9999-22-052-L01-P
Behring
1.5 4/7/2022 – 1:45-3:15 PM Session 4: Defining and Achieving 0530-9999-22-053-L01-P
Success Through Minimizing Infections
1.5 4/8/2022– 10:00-11:30 AM Session 6: Innovative Approaches to 0530-9999-22-054-L01-P
Patient Care: COVID-19 and beyond
1.25 4/8/2022 – 12:00-1:15 PM Satellite Symposium Presented by 0530-9999-22-055-L01-P
Mallinckrodt
1.5 4/8/2022 – 1:45-3:15 PM Session 7: Success in Organ Allocation: 0530-9999-22-056-L01-P
Opportunities in Innovation
1.5 4/8/2022 – 3:45-5:15 PM Session 8: Metrics in Transplantation: 0530-9999-22-057-L01-P
Envisioning the Ideal
This is a knowledge-based activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing continuing professional
development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 18 contact hours is provided by Global Education Group. Nurses should claim
only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component,
enables the participant to earn up to 18 medical knowledge MOC points in the American Board of Internal
Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points
equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s
responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC
credit.
Questions about Accreditation
For information about the accreditation of this program, please contact Global at 303-395-1782 or
CME@globaleducationgroup.com.
Scientific Program
The complete 2022 CEOT program schedule is available at https://www.myast.org/meetings/cutting-edge-
transplantation/ceot-2022/2022-ceot-program
Conflict of Interest Disclosures
Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for
Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for
Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating
those activities where continuing education credits are awarded must be balanced, independent, objective,
and scientifically rigorous. All persons in a position to control the content of an accredited continuingeducation program provided by Global are required to disclose all financial relationships with any ineligible
company within the past 24 months to Global. All financial relationships reported are identified as relevant
and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE
in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure
objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
Name of Faculty Reported Disclosed Relationships
David Al-Adra No Relevant Financial Relationships
Kenneth Anderoni No Relevant Financial Relationships
Medhat Askar Advisory Board with CareDx, Advisory Board with Immucor, Advisory Board with One
Lambda, Advisory Board with Hansa Biopharma, Advisory Board with Nephrosant
Lavanya Bellumkonda* Advisory Board and grant, fellowship or salary support from CareDx
John Belperio No Relevant Financial Relationships
Oriol Bestard No Relevant Financial Relationships
Therese Bittermann No Relevant Financial Relationships
Roy Bloom* Grant support and consultant with Veloxis, Grant, fellowship, or salary support from
CSL Behring, Grant support from CareDx, American Journal of Kidney Diseases
Editorial Board Associate Editor, Advisory Board with Allovir, Advisory Board with
Paladin Laboratories, Grant, fellowship, or salary support from Natera, Advisory
Board with Nephrosant
Emily Blumberg* Grant support from Takeda, Grant support and consultant with Merck, UpToDate
section editor, Shionogi Consulting fees/honoraria, Grant, fellowship, or salary
support from Hologic, amplyx DSMB member, AJT Editorial Board
Lyndsey Bowman Veloxis Speaker’s Bureau
Jonathan Bromberg Grant, fellowship, or salary support from Natera, Grant, fellowship, or salary support
from CareDX, Grant, fellowship, or salary support from MMDx, Eurofins Consulting
fees/honoraria
Patrica Chang No Relevant Financial Relationships
Matthew Cooper No Relevant Financial Relationships
Marta Crespo Advisory Board with Sanofi, Advisory Board with Novartis, Astellas Speaker’s
Bureau, Hansa Speaker’s Bureau, Coordinator Transplant Course Fellows &
Monographies with Chiesi
Lawrence Czer No Relevant Financial Relationships
Lara Danziger-Isakov Industry study with support to institution for enrollment with Astellas, Industry study
with support to institution for enrollment with Shire, Industry study with support to
institution for enrollment with Merck, Merck Consultant, Consulting fees/honoraria
with Takeda, DSMB with Merck, Pfizer Contracted clinical research, ISHLT President
Deepika Devuni* Grant, fellowship, or salary support from NIH, Site PI for a device study with Sequana
Medical
Arjang Djamali Consulting fees/honoraria with CareDX, Consulting fees/honoraria with CSL Behring
Andres Duarte-Rojo No Relevant Financial Relationships
Jeffery Edelman No Relevant Financial Relationships
Maria Isabel Fiel No Relevant Financial Relationships
David Foley No Relevant Financial Relationships
John Friedewald Sanofi Speaker’s Bureau, Transplant Genomics Consultant, Grant, fellowship, or
salary support from Veloxis, Grant, fellowship, or salary support from CSL Behring,
Grant, fellowship, or salary support from Eurofins, Grant, fellowship, or salary support
from NIAID, Grant, fellowship, or salary support from Hansa, Grant, fellowship, or
salary support from Viela Bio
Jon Friedman No Relevant Financial Relationships
Melissa Greenwald Consultant with Donor Alliance Colorado, Consultant with VRL Eurofins, Consultant
with John Brockington Foundation, Consultant with Thermo Fisher, Consultant with
Nevada Donor Network, Donate Life America Board of Directors, Laboratory Director
of CLIA (Moderate Complexity) Lab at Donor Alliance
Marlena Habal Bristol Myers Squibb Investigator initiated grant
Jonathan Hand Associate Medical Director Louisiana Organ Procurement Organization,
DSMB member Enzychem, Contracts for clinical research paid to institution with
Pfizer, Contracts for clinical research paid to institution with Janssen, Contracts for
clinical research paid to institution with GlaxoSmithKline, Contracts for clinical
research paid to institution with Rebiotix
Calvin Henry No Relevant Financial Relationships
Michelle Hickey Intellectual Property with Immucor
Bobby Howard No Relevant Financial RelationshipsName of Faculty Reported Disclosed Relationships
Syed Husain Grant, fellowship, or salary support from Nelson Family Foundation, Grant,
fellowship, or salary support from National Kidney Foundation, Grant, fellowship, or
salary support from NCATS
Mcihael Ison* Consulting fees/honoraria from Eurofins, Consulting fees/honoraria from Shionogi,
Consulting fees/honoraria from Cidara, Consulting fees/honoraria from Allovir,
Consulting fees/honoraria from ADMA Biologics, Consulting fees/honoraria from
Adagio, Consulting fees/honoraria from Transplant Infectious Diseases Journals,
Grant, fellowship, or salary support with Regeneron, Grant, fellowship, or salary
support with Pulmocide, Grant, fellowship, or salary support with GlaxoSmithKline,
DSMB with Takeda, DSMB with Merck, DSMB with Sequiris, DSMB with CSL
Behring, International Society of Influenza and Other Respiratory Vir,
Genentech/Roche
Susan Kaminsky No Relevant Financial Relationships
Dean Karvellas No Relevant Financial Relationships
Olivia Kates Consulting fees/honoraria with Canadian Society of Transplantation,
Consulting fees/honoraria with American Foundation for Donation and
Transplantation, Consulting fees/honoraria with Bennett Jones LLP
Jon Kobashigawa Grant Support and Advisory Board with CareDX, Grant Support with Sanofi,
Consulting fees/honoraria with TransMedics Inc.,
Grant, fellowship, or salary support from Massachusetts General Hospital, Research
with CSL Behring, Advisory Board with Novartis, Research Oversight Committee with
International Society for Heart and Lung Transplantation, Membership and
Professional Standards Committee with United Network for Organ Sharing
Beverly Kosmach-Park No Relevant Financial Relationships
Camille Kotton Consultant with Merck, Consultant with Hookipa, Advisory Board Takeda,
Consulting fees/honoraria with Roche Diagnostics, Consulting fees/honoraria with
Biotest
Michael Kriss Committee Member (Annual Meeting Education Committee) with AASLD,
Consulting fees/honoraria with Liver Health Connection, Consulting fees/honoraria
with Vivent Health, Controversies in Transplantation
Jasleen Kukreja No Relevant Financial Relationships
Vineeta Kumar* Veloxis Advisory Board, Member DSMB CareDx, Grant, fellowship, or salary support
from United Therapeutics, CareDx Advisory Board, Consulting fees/honoraria from
Mallinckrodt, ASN Speaker, Annual meeting Precourse, NKF
Speaker, NKF Annual Spring Meeting, NKF Regional Meetings
Daniela Lamas No Relevant Financial Relationships
Carmen Lefaucheur No Relevant Financial Relationships
Krista Lentine Consulting fees/honoraria from CareDx, Sanofi Speaker’s Bureau
Deborah Levine* No Relevant Financial Relationships
Josh Levitsky Consultant with Transplant Genomics, Consulting fees/honoraria from Mallinckrodt,
AASLD Co-Chair, Grant, fellowship, or salary support from Novartis
Joren Madsen Consulting fees/honoraria from CSL Behring, Transmedics Advisory Board
Roslyn Mannon Vitaeris Advisory Board, Verici Dx Advisory Board, AST/ASTS Deputy Editor Am Jnl
Transplant, Transplantation Society Chair, Women in Transplantation Initiative,
American Society of Nephrology Chair Policy and Advocacy Advisory Committee,
Scientific Registry of Transplant Recipients Co Chair, SRTR Review Committee,
Grant, fellowship, or salary support from Verici DX, Consulting fees/honoraria from
Olaris
Gary Marklin No Relevant Financial Relationships
George Mazariegos No Relevant Financial Relationships
Molly McCarthy No Relevant Financial Relationships
Sumit Mohan Angion Advisory Board, Kidney International Reports, Grant, fellowship, or salary
support from Angion Biomedica, SRTR member of visiting committee, UNOS Data
Advisory Committee, ASN Member, Quality Committee, HSAG National Faculty
Chair for ETCLC
Anna Morris No Relevant Financial Relationships
Mitra Nadim Consulting fees/honoraria from Mallinckrodt
Kenneth Newell* Hansa Advisory Board, Novartis Advisory Board, ITB-Med Advisory Board, Angion
Advisory Board, Talaris Advisory Board, Takeda Advisory Board, Sangamo Advisory
Board, Immucor Advisory Board, Consulting fees/honoraria from Natera
Peter Nickerson* Consulting with CSL Behring, Consulting fees/honoraria from Astellas, Consulting
fees/honoraria from Paladin Labs Inc
Jeff Orlowski No Relevant Financial Relationships
Rachel Patzer* No Relevant Financial RelationshipsName of Faculty Reported Disclosed Relationships
Elizabeth Pavlisko No Relevant Financial Relationships
Katie Ross No Relevant Financial Relationships
Joanna Schaenman* No Relevant Financial Relationships
Thomas Schiano No Relevant Financial Relationships
Carrie Schinstock No Relevant Financial Relationships
Jesse Schold Sanofi, Inc Speaker's Bureau, eGenesis consulting for research projects, NephroSant
Inc consulting for research projects, Lumicell DSMB member, Medeor Inc DSMB
member, Bristol-Myers Squibb DSMB member
Marina Serper Consulting fees/honoraria from Gilead Inc
Amy Silverstein No Relevant Financial Relationships
Lianne Singer Clinical trial funding from Incyte, Intellectual Property with UpToDate, Altavant
Advisory Board, Zambon Advisory Board
Jon Snyder Donate Life America Secretary of the Board, The Organ Donation and
Transplantation Alliance Board Member, LifeSource Clinical Policy Board Member
Darren Stewart No Relevant Financial Relationships
David Taber Grant Support from Veloxis, Grant, fellowship, or salary support from CareDx, Grant,
fellowship, or salary support from Merck, Consulting fees/honoraria from Veloxis
Anat Tambur* Core lab for multi-center trials for Sanofi, Core lab for multi-center trials for Viela Bio
Jane Tan Genentech/Roche Spouse employment and options
Jean-Luc Taupin No Relevant Financial Relationships
Seda Tierney No Relevant Financial Relationships
Sri Lekha Tummalapalli No Relevant Financial Relationships
Nicole Valenzuela No Relevant Financial Relationships
Chris Wiebe No Relevant Financial Relationships
Scott Winder No Relevant Financial Relationships
Cameron Wolfe No Relevant Financial Relationships
*Program planning committee member
The planners and managers have the following relevant financial relationships with ineligible companies:
Name of Planner or Manager Reported Financial Relationship
Rhys Williams, MSN, FNP-C,
Nothing to disclose
RN
Lindsay Borvansky Nothing to disclose
Andrea Funk Nothing to disclose
Liddy Knight Nothing to disclose
Ashley Cann Nothing to disclose
Jessica Perper Nothing to disclose
JoAnn Gwynn Nothing to disclose
Michelle Edelstein Nothing to disclose
Amber Nolan Nothing to disclose
Charlotte Aguilar Nothing to disclose
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are
not indicated by the FDA. Global Education Group (Global) and American Society of Transplantation do not
recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent
the views of any organization associated with this activity. Please refer to the official prescribing information
for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient
outcomes and their own professional development. The information presented in this activity is not meant to
serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or
treatment discussed in this activity should not be used by clinicians without evaluation of patient conditionsand possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Fee Information & Refund/Cancellation Policy Registration fees were collected for this activity. No refunds are permitted after March 6th, 2022.
You can also read
